Innovating antibody design driven by artificial intelligence

Dr. Dante Ricci, a scientist in the Synthetic Biology group at Lawrence Livermore National Laboratory (LLNL), is at the forefront of revolutionizing medical countermeasure development through artificial intelligence (AI).